Announced details
Used in frailty prevention classes conducted by Bunkyo City (period and number of uses not disclosed)
WalkCare was jointly developed with Morinomiya University of Medical Sciences. At 大阪ベイクりニック, the product is being used in insured medical care. Research and development is being conducted with the Institute of Inclusive Medical Science, Morinomiya University of Medical Sciences. The product was used in frailty prevention classes conducted by Bunkyo City.
Morinomiya University of Medical Sciences is the joint development partner. 大阪ベイクりニック is an affiliated facility of the university. The Institute of Inclusive Medical Science, Morinomiya University of Medical Sciences is the joint research partner. Bunkyo City is the local government that conducted frailty prevention classes. Other details, including locations, representatives, capital and year of establishment, are not disclosed.
General medical device (Class I)
Notification filed with the Pharmaceuticals and Medical Devices Agency (PMDA)
大阪ベイクりニック (location not disclosed)
The company states that it plans to position the product as one of the core products in its medical AI business and pursue business expansion. The specific impact on sales and profit is not disclosed.
The company does not address Contract Value / Offering price.
Ministry of Health, Labour and Welfare, “Report on Measures for Musculoskeletal Diseases to Promote the Prevention of Long-Term Care”
| Item | Details |
|---|---|
| Names of Products / Services Covered | AI gait analysis tool WalkCare, Remote rehabilitation support system |
| Counterparty | Morinomiya University of Medical Sciences, 大阪ベイクりニック, Institute of Inclusive Medical Science, Morinomiya University of Medical Sciences, Bunkyo City |
| Counterparty overview | Morinomiya University of Medical Sciences is the joint development partner. 大阪ベイクりニック is an affiliated facility of the university. The Institute of Inclusive Medical Science, Morinomiya University of Medical Sciences is the joint research partner. Bunkyo City is the local government that conducted frailty prevention classes. Other details, including locations, representatives, capital and year of establishment, are not disclosed. |
| Relationship with the Company | WalkCare was jointly developed with Morinomiya University of Medical Sciences. At 大阪ベイクりニック, the product is being used in insured medical care. Research and development is being conducted with the Institute of Inclusive Medical Science, Morinomiya University of Medical Sciences. The product was used in frailty prevention classes conducted by Bunkyo City. |
| Launch date | 26 August 2026, commencement of use in insured medical care (actual use) |
| Applicable area | Insured medical care, Motion analysis test, Frailty prevention, Visualization of the recovery of walking function after treatment in patients with osteoarthritis of the knee, Remote rehabilitation support |
| Award/certification name | General medical device (Class I) |
| Awarding / certifying body | Notification filed with the Pharmaceuticals and Medical Devices Agency (PMDA) |
| Location | 大阪ベイクりニック (location not disclosed) |
| Usage history | Used in frailty prevention classes conducted by Bunkyo City (period and number of uses not disclosed) |
| Impact on Business Performance | The company states that it plans to position the product as one of the core products in its medical AI business and pursue business expansion. The specific impact on sales and profit is not disclosed. |
| Source | Ministry of Health, Labour and Welfare, “Report on Measures for Musculoskeletal Diseases to Promote the Prevention of Long-Term Care” |
Items this document does not state (6)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Health issues associated with declining walking function, including frailty and osteoarthritis of the knee, are increasing as the population ages. Previously, it was difficult to evaluate walking conditions objectively and quantitatively.